BNP Paribas Financial Markets
VERA icon

BNP Paribas Financial Markets’s Vera Therapeutics VERA Stock Holding History

BNP Paribas Financial Markets’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$517K Sell
12,056
-286,093
-96% -$10.7M ﹤0.01% 3745
2026
Q1 		$12M Sell
298,149
-176,519
-37% -$7.61M 0.01% 1468
2025
Q4 		$24M Buy
474,668
+220,692
+87% +$7.84M 0.01% 1073
2025
Q3 		$7.38M Buy
253,976
+143,424
+130% +$3.32M ﹤0.01% 1735
2025
Q2 		$2.6M Buy
110,552
+92,108
+499% +$2.07M ﹤0.01% 2296
2025
Q1 		$443K Sell
18,444
-5,930
-24% -$191K ﹤0.01% 3261
2024
Q4 		$1.03M Buy
+24,374
New +$1.08M ﹤0.01% 2808
2022
Q4 		– Sell
-5,183
Closed -$110K – 4637
2022
Q3 		$110K Buy
+5,183
New +$97K ﹤0.01% 3726

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BNP Paribas Financial Markets's VERA Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Vera Therapeutics (VERA) stake by 96% in Q2 2026, selling an estimated $10.7M and leaving 12,056 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #3745.

BNP Paribas Financial Markets first reported a position in VERA in Q3 2022 and has held it in 8 quarters since. The position peaked at $24M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • BNP Paribas Financial Markets held 12,056 shares of Vera Therapeutics worth $517K as of Q2 2026.
  • BNP Paribas Financial Markets sold 286,093 Vera Therapeutics shares in Q2 2026, an estimated $10.7M.
  • Vera Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3745 holding.
  • BNP Paribas Financial Markets first reported a position in Vera Therapeutics in Q3 2022 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Vera Therapeutics position peaked at $24M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.